A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

Clinical trial NCT05929079 · COMPLETED

Trial details

NCT number: NCT05929079
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Obesity Overweight Obstructive Sleep Apnea

Start date: 2023-07-11
Primary completion: 2026-06-16
Enrollment: 1152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.